PA
VNDA icon

Perceptive Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Perceptive Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-36,232
Closed -$649K – 156
2017
Q3 		$649K Hold
36,232
– – 0.02% 112
2017
Q2 		$591K Hold
36,232
– – 0.03% 110
2017
Q1 		$507K Buy
+36,232
New +$516K 0.03% 121
2016
Q2 		– Sell
-71,849
Closed -$601K – 204
2016
Q1 		$601K Hold
71,849
– – 0.05% 108
2015
Q4 		$669K Buy
+71,849
New +$717K 0.05% 93
2015
Q2 		– Hold
0
– – – 194
2015
Q1 		– Hold
0
– – – 177
2014
Q4 		– Hold
0
– – – 168
2014
Q3 		– Hold
0
– – – 144
2013
Q4 		– Sell
-868,500
Closed -$9.51M – 140
2013
Q3 		$9.51M Buy
+868,500
New +$9.28M 0.83% 35

Other funds holding VNDA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return